Alpha-1 Research Registry
NCT04157049 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2024-01-30
Summary
The Alpha-1 Research Registry is a confidential database made up of individuals diagnosed with Alpha-1 Antitrypsin Deficiency (Alpha-1) and individuals identified as Alpha-1 carriers. The Registry was established to facilitate research initiatives and promote the development of improved treatments and a cure for Alpha-1.
Conditions
Sponsors & Collaborators
-
Alpha-1 Foundation
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-20
- Primary Completion
- 2029-06-20
- Completion
- 2029-06-20
Countries
- United States
Study Locations
More Related Trials
-
A National Registry on Chinese Patients With Cystic Fibrosis
NCT05289245 ·Status: RECRUITING
-
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
NCT01851642 ·Status: RECRUITING
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations
NCT03256799 ·Status: COMPLETED ·Phase: PHASE4
-
Breath Condensate Study in Patients With Cystic Fibrosis.
NCT02056132 ·Status: COMPLETED
-
Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
NCT00585364 ·Status: COMPLETED
-
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
NCT02477319 ·Status: COMPLETED
-
Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients
NCT00499837 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis
NCT01799642 ·Status: COMPLETED
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
NCT06504589 ·Status: RECRUITING
-
Quantitation and Spatial Registration of Airways Dysfunction With Dynamic 19F MRI in Cystic Fibrosis
NCT06057714 ·Status: RECRUITING
-
Combating Diagnostic Wandering and Impasse for Cystic Fibrosis
NCT05654480 ·Status: UNKNOWN
-
Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis
NCT02853175 ·Status: COMPLETED
-
Ketone Supplementation in Cystic Fibrosis
NCT04938726 ·Status: COMPLETED ·Phase: NA
-
Registry Study on Cystic Fibrosis in Chinese Children
NCT02753374 ·Status: NOT_YET_RECRUITING
-
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822 ·Status: COMPLETED
-
Regional Monitoring of CF Lung Disease
NCT06339593 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Cystic Fibrosis Related Bone Disease: the Role of CFTR
NCT01549314 ·Status: COMPLETED
-
Measures of Respiratory Health Registry
NCT05501587 ·Status: RECRUITING
-
Development a Core Set for Adults With Cystic Fibrosis Based on the ICF
NCT06128499 ·Status: COMPLETED
-
The Fibrodysplasia Ossificans Progressiva (FOP) Registry
NCT02745158 ·Status: RECRUITING
-
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease
NCT00807482 ·Status: RECRUITING
-
Small Circulating RNA as Molecular Markers of Lung Disease in Cystic Fibrosis
NCT02992080 ·Status: COMPLETED ·Phase: NA
-
MRI in Cystic Fibrosis and Primary Ciliary Dyskinesia
NCT03279965 ·Status: UNKNOWN